Number of patients |
255 |
Sex, n (%) |
|
Male |
212 (83.1) |
Female |
43 (16.9) |
Smoking, n (%) |
|
Never |
66 (25.8) |
Former |
97 (38.1) |
Current |
92 (36.1) |
Smoking intensity, n (%) |
|
Never |
66 (25.8) |
High |
74 (29.1) |
Low |
115 (45.1) |
Age at UBC diagnosis, years, median (IQR) |
78 (74–82) |
Age at RC, years, median (IQR) |
79 (75–83) |
Preoperative BMI, kg/m2, median (IQR) |
23.4 (20.4–28.3) |
Previous radiotherapy treatment, n (%) |
|
No |
251 (98.4) |
Yes |
4 (1.6) |
ECOG PS score, n (%) |
|
0 |
139 (54.5) |
1 |
103 (40.4) |
2 |
13 (5.1) |
ASA score, median (IQR) |
3 (2–4) |
CCI score, median (IQR) |
3 (2–4) |
Clinical T stage, n (%) |
|
T1 |
12 (4.7) |
T2 |
170 (67.2) |
T3 |
56 (22.1) |
T4 |
15 (5.9) |
Clinical N stage, n (%) |
|
N0 |
241 (94.5) |
N+ |
14 (5.5) |
Preoperative haemoglobin, g/dL, median (IQR) |
13.2 (11.7–14.5) |
Preoperative albumin, g/dL, median (IQR) |
4.2 (3.9–4.4) |
Preoperative CRP, mg/L, median (IQR) |
8.8 (6.7–11.5) |
mGPS, n (%) |
|
0 |
125 (49.0) |
1 |
82 (32.2) |
2 |
48 (18.8) |
Hydronephrosis, n (%) |
|
No |
189 (74.1) |
Yes |
66 (25.9) |
Preoperative eGFR, mL/min/1.73 m2, median (IQR) |
69.70 (49.27–89.70) |
Preoperative fibrinogen level, mg/dL, median (IQR) |
361 (299–442) |
Preoperative NLR, median (IQR) |
2.37 (1.61–3.53) |
Preoperative total cholesterol level, mg/dL, median (IQR) |
221 (187–263) |
Preoperative HDL level, mg/dL, median (IQR) |
49 (43–57) |